Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized 2x2 Factorial Trial Comparing the Cre8 Amphilimus-sirolimus Eluting Stent vs. the Synergy Everolimus-eluting Stent and a Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-comers Patients Undergoing Percutaneous Coronary Intervention

NCT04135989 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT04135989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04135989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized 2x2 Factorial Trial Comparing the Cre8 Amphilimus-sirolimus Eluting Stent vs. the Synergy Everolimus-eluting Stent and a Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-comers Patients Undergoing Percutaneous Coronary Intervention
Lead sponsor
Federico II University
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2020
Completion date
October 24, 2024
Enrollment
2,106 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, chronic coronary syndrome, coronary artery disease, myocardial infarction